Thank you, Ms. Chairman.
The first question, could you provide the definitions of the terms used in the post-market surveillance, so we can have that on the record for the committee—terms such as “drug medical device”, “drug review process”. Obviously the words we use are important, so it would be helpful to get your definitions.